Other Species / Isoforms
  LATS2 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
T5-p
___MRPKtFPAttys
0 1
LATS2 (human) ___MRPKtFPAttys T5-p
LATS2 (mouse) ___MRPKTFPATTYS T5
LATS2 (rat) ___MRPKTFPATTYS T5
T9-p
RPKtFPAttysGNSR
0 1
LATS2 (human) RPKtFPAttysGNSR T9-p
LATS2 (mouse) RPKTFPATTYSGNSR T9
LATS2 (rat) RPKTFPATTYSGNSR T9
T10-p
PKtFPAttysGNSRQ
0 1
LATS2 (human) PKtFPAttysGNSRQ T10-p
LATS2 (mouse) PKTFPATTYSGNSRQ T10
LATS2 (rat) PKTFPATTYSGNSRQ T10
Y11-p
KtFPAttysGNSRQR
0 1
LATS2 (human) KtFPAttysGNSRQR Y11-p
LATS2 (mouse) KTFPATTYSGNSRQR Y11
LATS2 (rat) KTFPATTYSGNSRQR Y11
S12-p
tFPAttysGNSRQRL
0 1
LATS2 (human) tFPAttysGNSRQRL S12-p
LATS2 (mouse) TFPATTYSGNSRQRL S12
LATS2 (rat) TFPATTYSGNSRQRL S12
K27
QEIREGLKQPSKSSV
0 1
LATS2 (human) QEIREGLKQPSKSSV K27
LATS2 (mouse) QEIREGLkQPSkAST K27-ub
LATS2 (rat) QEIREGLKQPAKSST K27
K31
EGLKQPSKSSVQGLP
0 1
LATS2 (human) EGLKQPSKSSVQGLP K31
LATS2 (mouse) EGLkQPSkASTQGLL K31-ub
LATS2 (rat) EGLKQPAKSSTQGLL K31
S43-p
GLPAGPNsDTSLDAk
0 1
LATS2 (human) GLPAGPNsDTSLDAk S43-p
LATS2 (mouse) GLLVGPNSDTSLDAk S43
LATS2 (rat) GLLVGPNSDTSSLDA S43
K50-ub
sDTSLDAkVLGSkDA
0 2
LATS2 (human) sDTSLDAkVLGSkDA K50-ub
LATS2 (mouse) SDTSLDAkVLGSKDA K50-ub
LATS2 (rat) DTSSLDAKVLGNKDA K51
K55-ac
DAkVLGSkDATRQQQ
0 1
LATS2 (human) DAkVLGSkDATRQQQ K55-ac
LATS2 (mouse) DAkVLGSKDASRQQQ K55
LATS2 (rat) DAKVLGNKDASRQQQ K56
K55-ub
DAkVLGSkDATRQQQ
0 1
LATS2 (human) DAkVLGSkDATRQQQ K55-ub
LATS2 (mouse) DAkVLGSKDASRQQQ K55
LATS2 (rat) DAKVLGNKDASRQQQ K56
Y82-p
KALREIRysLLPFAN
0 2
LATS2 (human) KALREIRysLLPFAN Y82-p
LATS2 (mouse) KALREIRYSLLPFAN Y81
LATS2 (rat) KALREIRYSLLPFAN Y82
S83-p
ALREIRysLLPFANE
Upstream
Downstream
4 0
Effects on Modified Protein
  • intracellular localization
Effects on Biological Processes:
  • cell cycle regulation
Kinase, in vitro:
  • AurA (human)
Putative in vivo kinases:
  • AurA (human)
Treatment
  • AZD1152
  • MLN8054
  • nocodazole
  • VX-680
LATS2 (human) ALREIRysLLPFANE S83-p
LATS2 (mouse) ALREIRYSLLPFANE S82
LATS2 (rat) ALREIRYSLLPFANE S83
Y135-p
SIEAALEyISKMGYL
0 1
LATS2 (human) SIEAALEyISKMGYL Y135-p
LATS2 (mouse) SIEAALEYISKMGYL Y134
LATS2 (rat) SIEAALEYISKMGYL Y135
K154
EQIVRVIKQTSPGKG
0 1
LATS2 (human) EQIVRVIKQTSPGKG K154
LATS2 (mouse) EQIVRVIkQTSPGkG K153-ac
LATS2 (rat) EQIVRVIKQTSPGKG K154
K154-ub
EQIVRVIkQTSPGKG
0 1
LATS2 (human) EQIVRVIkQTSPGKG K154-ub
LATS2 (mouse) EQIVRVIKQTSPGkG K153
LATS2 (rat) EQIVRVIKQTSPGKG K154
K160
IkQTSPGKGLMPTPV
0 1
LATS2 (human) IkQTSPGKGLMPTPV K160
LATS2 (mouse) IkQTSPGkGLAPTPV K159-ac
LATS2 (rat) IKQTSPGKGLVPTAV K160
T168-gl
GLMPTPVtRRPsFEG
Upstream
Downstream
1 1
Effects on Modified Protein
  • phosphorylation
Effects on Biological Processes:
  • carcinogenesis, induced
  • cell growth, induced
Treatment
  • siRNA
  • thiamet-G
LATS2 (human) GLMPTPVtRRPsFEG T168-gl
LATS2 (mouse) GLAPTPVTRRPSFEG T167
LATS2 (rat) GLVPTAVTRRPsFEG T168
S172-p
TPVtRRPsFEGTGDS
Upstream
2 5
Kinase, in vitro:
  • Chk2 (human)
LATS2 (human) TPVtRRPsFEGTGDS S172-p
LATS2 (mouse) TPVTRRPSFEGTGEA S171
LATS2 (rat) TAVTRRPsFEGTGEA S172-p
S274-p
YGVQRSPsFQSktPP
0 2
LATS2 (human) YGVQRSPsFQSktPP S274-p
LATS2 (mouse) YGVQRSSSFQNKTPP S262
LATS2 (rat) YGVQRSPSFQSKTPP S261
K278-ub
RSPsFQSktPPETGG
0 1
LATS2 (human) RSPsFQSktPPETGG K278-ub
LATS2 (mouse) RSSSFQNKTPPDAYS K266
LATS2 (rat) RSPSFQSKTPPDTYS K265
T279-p
SPsFQSktPPETGGy
0 2
LATS2 (human) SPsFQSktPPETGGy T279-p
LATS2 (mouse) SSSFQNKTPPDAYSS T267
LATS2 (rat) SPSFQSKTPPDTYSS T266
Y286-p
tPPETGGyAsLPTKG
0 35
LATS2 (human) tPPETGGyAsLPTKG Y286-p
LATS2 (mouse) NKTPPDAYSSMAKAQ Y272
LATS2 (rat) SKTPPDTYSSLAKAQ Y271
S288-p
PETGGyAsLPTKGQG
0 1
LATS2 (human) PETGGyAsLPTKGQG S288-p
LATS2 (mouse) TPPDAYSSMAKAQGG S274
LATS2 (rat) TPPDTYSSLAKAQGG S273
S342-p
SQVFASDsPPQSLLT
0 2
LATS2 (human) SQVFASDsPPQSLLT S342-p
LATS2 (mouse) GPTFTGESSAQAVLA S326
LATS2 (rat) GPTFTGDSSTQAVLA S325
S380-p
ATLARRDsLQKPGLE
Upstream
Downstream
2 22
Effects on Modified Protein
  • intracellular localization
Kinase, in vitro:
  • AurA (human)
  • Chk2 (human)
Putative in vivo kinases:
  • AurA (human)
LATS2 (human) ATLARRDsLQKPGLE S380-p
LATS2 (mouse) APLARRDsLQKQGLE S362-p
LATS2 (rat) APLARRDSLQKQSLE S361
S408-p
PVPSRTNsFNSHQPR
Upstream
Downstream
2 5
Effects on Modified Protein
  • activity, induced
Effects on Biological Processes:
  • apoptosis, inhibited
  • cell cycle regulation
  • signaling pathway regulation
Kinase, in vitro:
  • Chk2 (human)
Putative in vivo kinases:
  • Chk1 (human)
Regulatory protein:
  • Chk1 (human)
Treatment
  • Chk2_inhibitor_II
  • SB218078
  • siRNA
  • UV
LATS2 (human) PVPSRTNsFNSHQPR S408-p
LATS2 (mouse) AGPSRTNSFNNPQPE S386
LATS2 (rat) AGPSRTNSFSSPQPE S385
T436-gl
PNTVTAVtAAHILHP
Upstream
Downstream
1 1
Effects on Modified Protein
  • enzymatic activity, inhibited
  • molecular association, regulation
  • phosphorylation
Effects on Biological Processes:
  • carcinogenesis, induced
  • cell growth, induced
  • signaling pathway regulation
Treatment
  • siRNA
  • thiamet-G
LATS2 (human) PNTVTAVtAAHILHP T436-gl
LATS2 (mouse) PNTVTAVTAAHILHP T406
LATS2 (rat) PNTVTAVTAAHILHP T405
S446-p
HILHPVKsVRVLRPE
Upstream
1 0
Kinase, in vitro:
  • Chk2 (human)
LATS2 (human) HILHPVKsVRVLRPE S446-p
LATS2 (mouse) HILHPVKSVRVLRPE S416
LATS2 (rat) HILHPVKSVRVLRPE S415
S528-p
HLLLRSKsEQyDLDs
0 3
LATS2 (human) HLLLRSKsEQyDLDs S528-p
LATS2 (mouse) HLLLPSKSEQYSVDL S485
LATS2 (rat) HLLLPSKSEQYSAGL S485
Y531-p
LRSKsEQyDLDsLCA
0 2
LATS2 (human) LRSKsEQyDLDsLCA Y531-p
LATS2 (mouse) LPSKSEQYSVDLDSL Y488
LATS2 (rat) LPSKSEQYSAGLDRL Y488
S535-p
sEQyDLDsLCAGMEQ
0 1
LATS2 (human) sEQyDLDsLCAGMEQ S535-p
LATS2 (mouse) QYSVDLDSLCTSVQQ S494
LATS2 (rat) QYSAGLDRLCTGVEQ R494
S543-p
LCAGMEQsLRAGPNE
0 1
LATS2 (human) LCAGMEQsLRAGPNE S543-p
LATS2 (mouse) LCTSVQQSLRGGTEQ S502
LATS2 (rat) LCTGVEQSLRGGTEQ S502
K565-ac
RKSAKGDkGGKDkkQ
0 1
LATS2 (human) RKSAKGDkGGKDkkQ K565-ac
LATS2 (mouse) HKGAKGDKAGRDKKQ K523
LATS2 (rat) HKGAKGDKAGRDKKQ K523
K570-ac
GDkGGKDkkQIQtsP
0 1
LATS2 (human) GDkGGKDkkQIQtsP K570-ac
LATS2 (mouse) GDKAGRDKKQIQTSP K528
LATS2 (rat) GDKAGRDKKQIQTSP K528
K571-ac
DkGGKDkkQIQtsPV
0 1
LATS2 (human) DkGGKDkkQIQtsPV K571-ac
LATS2 (mouse) DKAGRDKKQIQTSPV K529
LATS2 (rat) DKAGRDKKQIQTSPV K529
T575-p
KDkkQIQtsPVPVRK
0 1
LATS2 (human) KDkkQIQtsPVPVRK T575-p
LATS2 (mouse) RDKKQIQTSPVPVRK T533
LATS2 (rat) RDKKQIQTSPVPVRK T533
S576-p
DkkQIQtsPVPVRKN
0 4
LATS2 (human) DkkQIQtsPVPVRKN S576-p
LATS2 (mouse) DKKQIQTSPVPVRKN S534
LATS2 (rat) DKKQIQTSPVPVRKN S534
S598-p
ESRIKSYsPYAFKFF
0 1
LATS2 (human) ESRIKSYsPYAFKFF S598-p
LATS2 (mouse) ESRIKSYSPYAFKFF S556
LATS2 (rat) ESRIKSYSPYAFKFF S556
K620-ub
VIKTYQQkVNRRLQL
0 1
LATS2 (human) VIKTYQQkVNRRLQL K620-ub
LATS2 (mouse) VIKTYQQKVSRRLQL K578
LATS2 (rat) VIKTYQQKVSRRLQL K578
K651-ub
MRKILYQkESNYNRL
0 1
LATS2 (human) MRKILYQkESNYNRL K651-ub
LATS2 (mouse) MRKILYQKESNYNRL K609
LATS2 (rat) MRKILYQKESNYNRL K609
T690-p
CLACKVDtHALYAMk
0 1
LATS2 (human) CLACKVDtHALYAMk T690-p
LATS2 (mouse) CLACKLDTHALYAMK T648
LATS2 (rat) CLACKVDTHALYAMK T648
K697-ub
tHALYAMkTLRKKDV
0 1
LATS2 (human) tHALYAMkTLRKKDV K697-ub
LATS2 (mouse) THALYAMKTLRKKDV K655
LATS2 (rat) THALYAMKTLRKKDV K655
K793-ub
GFIHRDIkPDNILID
0 1
LATS2 (human) GFIHRDIkPDNILID K793-ub
LATS2 (mouse) GFIHRDIKPDNILID K751
LATS2 (rat) GFIHRDIKPDNILID K751
Y824
RWTHNSKYYQkGSHV
0 1
LATS2 (human) RWTHNSKYYQkGSHV Y824
LATS2 (mouse) RWTHNSKyyQKGNHM Y782-p
LATS2 (rat) RWTHNSKYYQKGNHI Y782
Y825
WTHNSKYYQkGSHVR
0 1
LATS2 (human) WTHNSKYYQkGSHVR Y825
LATS2 (mouse) WTHNSKyyQKGNHMR Y783-p
LATS2 (rat) WTHNSKYYQKGNHIR Y783
K827-ub
HNSKYYQkGSHVRQD
0 1
LATS2 (human) HNSKYYQkGSHVRQD K827-ub
LATS2 (mouse) HNSKyyQKGNHMRQD K785
LATS2 (rat) HNSKYYQKGNHIRQD K785
S835-p
GSHVRQDsMEPSDLW
Upstream
Downstream
2 1
Effects on Modified Protein
  • activity, induced
  • enzymatic activity, induced
  • phosphorylation
Effects on Biological Processes:
  • apoptosis, induced
  • signaling pathway regulation
Kinase, in vitro:
  • Chk1 (human)
  • LATS2 (human)
Putative in vivo kinases:
  • Chk1 (human)
Regulatory protein:
  • Chk1 (human)
Treatment
  • UV
LATS2 (human) GSHVRQDsMEPSDLW S835-p
LATS2 (mouse) GNHMRQDSMEPGDLW S793
LATS2 (rat) GNHIRQDSMEPGDLW S793
S846
SDLWDDVSNCRCGDR
0 1
LATS2 (human) SDLWDDVSNCRCGDR S846
LATS2 (mouse) GDLWDDVsNCRCGDR S804-p
LATS2 (rat) GDLWDDVSNCRCGDR S804
S872-p
HQRCLAHsLVGTPNY
Upstream
Downstream
3 17
Effects on Biological Processes:
  • cell growth, induced
  • transcription, inhibited
Regulatory protein:
  • GRF-1 (human)
  • OGT (human)
LATS2 (human) HQRCLAHsLVGTPNY S872-p
LATS2 (mouse) HQRCLAHsLVGTPNY S830-p
LATS2 (rat) HQRCLAHSLVGTPNY S830
K939-ub
LHIPAQVkLSPEARD
0 1
LATS2 (human) LHIPAQVkLSPEARD K939-ub
LATS2 (mouse) LHIPTQVRLSAEARD R897
LATS2 (rat) LHIPTQVKLSAEARD K897
K950-ub
EARDLITkLCCSADH
0 1
LATS2 (human) EARDLITkLCCSADH K950-ub
LATS2 (mouse) EARDLITKLCCAADC K908
LATS2 (rat) EARDLITKLCCAADC K908
K968-ub
RNGADDLkAHPFFSA
0 1
LATS2 (human) RNGADDLkAHPFFSA K968-ub
LATS2 (mouse) RDGADDLKAHPFFNt K926
LATS2 (rat) RDGADDLKAHPFFST K926
A975
kAHPFFSAIDFSSDI
0 1
LATS2 (human) kAHPFFSAIDFSSDI A975
LATS2 (mouse) KAHPFFNtIDFSRDI T933-p
LATS2 (rat) KAHPFFSTIDFSRDI T933
K984-ub
DFSSDIRkQPAPYVP
0 1
LATS2 (human) DFSSDIRkQPAPYVP K984-ub
LATS2 (mouse) DFSRDIRKQPAPYVP K942
LATS2 (rat) DFSRDIRKQPAPYVP K942
T1024-p
GSTKAWDtLtsPNNK
0 1
LATS2 (human) GSTKAWDtLtsPNNK T1024-p
LATS2 (mouse) ESAKAWDTLASPSSK T982
LATS2 (rat) ESAKAWDTLASPNSK T982
T1026-p
TKAWDtLtsPNNKHP
0 1
LATS2 (human) TKAWDtLtsPNNKHP T1026-p
LATS2 (mouse) AKAWDTLASPSSKHP A984
LATS2 (rat) AKAWDTLASPNSKHP A984
S1027-p
KAWDtLtsPNNKHPE
0 3
LATS2 (human) KAWDtLtsPNNKHPE S1027-p
LATS2 (mouse) KAWDTLASPSSKHPE S985
LATS2 (rat) KAWDTLASPNSKHPE S985
T1041-p
EHAFYEFtFRRFFDD
Upstream
Downstream
6 0
LATS2 (human)
T1041-p
LATS2 (mouse)
T999-p
LATS2 (rat)
T999-p
Effects on Modified Protein
  • activity, induced
  • enzymatic activity, induced
  • phosphorylation
Effects on Biological Processes:
  • carcinogenesis, inhibited
  • cell growth, inhibited
  • signaling pathway regulation
Regulatory protein:
  • MST1 (human)
  • MST2 (human)
  • OGT (human)
Treatment
  • stiff ECM substrate
  • U73122
LATS2 (human) EHAFYEFtFRRFFDD T1041-p
LATS2 (mouse) EHAFYEFTFRRFFDD T999
LATS2 (rat) EHAFYEFtFRRFFDD T999-p
Y1051-p
RFFDDNGyPFRCPKP
1 1
LATS2 (human) RFFDDNGyPFRCPKP Y1051-p
LATS2 (mouse) RFFDDNGYPFRCPKP Y1009
LATS2 (rat) RFFDDNGyPFRCPKP Y1009-p